Eisler Capital (UK)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$50.2M Buy
56,607
+13,396
+31% +$12M 0.23% 92
2024
Q2
$39.1M Buy
43,211
+12,446
+40% +$9.96M 0.25% 101
2024
Q1
$23.9M Sell
30,765
-316
-1% -$225K 0.2% 127
2023
Q4
$18.1M Buy
31,081
+15,880
+104% +$9.27M 0.14% 145
2023
Q3
$8.17M Buy
15,201
+14,601
+2,434% +$7.52M 0.05% 233
2023
Q2
$281K Buy
+600
New +$252K ﹤0.01% 344

Other funds holding LLY

Eisler Capital (UK)'s LLY Position: Q1 2024 in Review

Eisler Capital (UK) sold out of Eli Lilly (LLY) in Q1 2024, closing a stake of 1,238 shares — an estimated $881K sold.

Eisler Capital (UK) first reported a position in LLY in Q4 2023 and held it in 1 quarter. The position peaked at $722K in Q4 2023. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • Eisler Capital (UK) reported no remaining Eli Lilly position as of Q1 2024 after selling out during the quarter.
  • Eisler Capital (UK) sold 1,238 Eli Lilly shares in Q1 2024, an estimated $881K.
  • Eisler Capital (UK) first reported a position in Eli Lilly in Q4 2023 and held it in 1 quarter.
  • Eisler Capital (UK)'s Eli Lilly position peaked at $722K in Q4 2023.
  • 3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Eisler Capital (UK)'s 13F filing for Q1 2024, filed 14 May 2024.